Drug Type Gene therapy |
Synonyms GENE202 |
Target- |
Mechanism- |
Active Indication |
Inactive Indication- |
Originator Organization GeneSpire SrlStartup |
Active Organization GeneSpire SrlStartup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Methylmalonic Acidemia | Preclinical | IT | GeneSpire SrlStartup | 30 Sep 2024 |